Anti-APP (Crenezumab)-SPDB-DM4 ADC

CAT:

708-ADC-W-687

Size:

1 mg

Price:

Ask

For price, please contact [email protected]

Description: This ADC product is comprised of an anti-APP monoclonal antibody conjugated via a SPDB linker to DM4. The DM4 is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, DM1 binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
CAS Number: 9007-83-4
Format: Solution
Shipping Conditions: Ice Packs
Storage Conditions: -20°C

Cat	Name
ADC-W-687	Anti-APP (Crenezumab)-SPDB-DM4 ADC
ADC-W-1389	Anti-IL5 (Crenezumab)-SPDB-DM4 ADC
ADC-W-1227	Anti-IFNG (Crenezumab)-SPDB-DM4 ADC
ADC-W-2499	Anti-ITGA4+ITGB7 (Crenezumab)-SPDB-DM4 ADC
ADC-W-705	Anti-APP (Bapineuzumab)-SPDB-DM4 ADC
ADC-W-699	Anti-APP (Solanezumab)-SPDB-DM4 ADC
ADC-W-711	Anti-APP (Ponezumab)-SPDB-DM4 ADC
ADC-W-681	Anti-APP (Gantenerumab)-SPDB-DM4 ADC
ADC-W-693	Anti-APP (Aducanumab)-SPDB-DM4 ADC
ADC-S-010	SPDB-DM4